摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-benzyloxyindan-1-carboxylic acid | 405102-97-8

中文名称
——
中文别名
——
英文名称
4-benzyloxyindan-1-carboxylic acid
英文别名
4-phenylmethoxy-2,3-dihydro-1H-indene-1-carboxylic acid
4-benzyloxyindan-1-carboxylic acid化学式
CAS
405102-97-8
化学式
C17H16O3
mdl
——
分子量
268.312
InChiKey
RSYSXZURIMKMNF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    [(1-ethylpyrazol-4-yl)methyl](4-isopropylphenyl)amine4-benzyloxyindan-1-carboxylic acid 以4-benzyloxy-N-[(1-ethylpyrazol-4-yl)methyl]-N-(4-isopropylphenyl)indan-1-carboxamide (0.79 g) was obtained的产率得到4-benzyloxy-N-[(1-ethylpyrazol-4-yl)methyl]-N-(4-isopropylphenyl)indan-1-carboxamide
    参考文献:
    名称:
    Novel amide derivatives and medicinal use thereof ugs
    摘要:
    本发明涉及一种式(1)的酰胺衍生物,具有C5a受体拮抗作用,其中每个符号如规范中所定义。上述酰胺衍生物及其光学活性形式和药学上可接受的盐被认为是治疗或预防因C5a引起的炎症引起的疾病或综合症的药物,如自身免疫性疾病,如风湿病,系统性红斑狼疮等,败血症,成人呼吸窘迫综合症,慢性阻塞性肺疾病,哮喘等过敏性疾病,动脉粥样硬化,心脏梗死,脑梗死,牛皮癣,老年痴呆症和严重器官损伤(如肺炎,肾炎,肝炎,胰腺炎等)由于缺血再灌注,创伤,烧伤,手术入侵等引起的白细胞激活。此外,它们对通过C5a受体侵入的细菌和病毒引起的传染病也有用作治疗或预防剂。
    公开号:
    US20040138223A1
  • 作为产物:
    参考文献:
    名称:
    NOVEL AMIDE DERIVATIVES AND MEDICINAL USE THEREOF
    摘要:
    公开号:
    EP1318140B9
点击查看最新优质反应信息

文献信息

  • Novel amide derivatives and medicinal use thereof ugs
    申请人:——
    公开号:US20040138223A1
    公开(公告)日:2004-07-15
    The present invention relates to an amide derivative of the formula (1), having a C5a receptor antagonistic action 1 wherein each symbol is as defined in the specification. The above-mentioned amide derivative, an optically active form thereof and a pharmaceutically acceptable salt thereof are promising as an agent for the treatment or prophylaxis of diseases or syndromes caused by inflammation caused by C5a [e.g., autoimmune diseases such as rheumatism, systemic lupus erythematosus and the like, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergic diseases such as asthma and the like, atherosclerosis, cardiac infarction, brain infarction, psoriasis, Alzheimer's disease and serious organ injury (e.g., pneumonia, nephritis, hepatitis and pancreatitis and the like) due to activation of leukocytes caused by ischemia reperfusion, trauma, burn, surgical invasion and the like]. Moreover, they are useful as a therapeutic or prophylactic agent for the infectious diseases caused by bacteria and virus that invade via a C5a receptor.
    本发明涉及一种式(1)的酰胺衍生物,具有C5a受体拮抗作用,其中每个符号如规范中所定义。上述酰胺衍生物及其光学活性形式和药学上可接受的盐被认为是治疗或预防因C5a引起的炎症引起的疾病或综合症的药物,如自身免疫性疾病,如风湿病,系统性红斑狼疮等,败血症,成人呼吸窘迫综合症,慢性阻塞性肺疾病,哮喘等过敏性疾病,动脉粥样硬化,心脏梗死,脑梗死,牛皮癣,老年痴呆症和严重器官损伤(如肺炎,肾炎,肝炎,胰腺炎等)由于缺血再灌注,创伤,烧伤,手术入侵等引起的白细胞激活。此外,它们对通过C5a受体侵入的细菌和病毒引起的传染病也有用作治疗或预防剂。
  • Novel amide derivatives and medicinal use thereof
    申请人:NAKAMURA Mitsubaru
    公开号:US20100041656A1
    公开(公告)日:2010-02-18
    The present invention relates to an amide derivative of the formula (1), having a C5a receptor antagonistic action wherein each symbol is as defined in the specification. The above-mentioned amide derivative, an optically active form thereof and a pharmaceutically acceptable salt thereof are promising as an agent for the treatment or prophylaxis of diseases or syndromes caused by inflammation caused by C5a [e.g., autoimmune diseases such as rheumatism, systemic lupus erythematosus and the like, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergic diseases such as asthma and the like, atherosclerosis, cardiac infarction, brain infarction, psoriasis, Alzheimer's disease and serious organ injury (e.g., pneumonia, nephritis, hepatitis and pancreatitis and the like) due to activation of leukocytes caused by ischemia reperfusion, trauma, burn, surgical invasion and the like]. Moreover, they are useful as a therapeutic or prophylactic agent for the infectious diseases caused by bacteria and virus that invade via a C5a receptor.
    本发明涉及一种式(1)的酰胺衍生物,具有C5a受体拮抗作用,其中每个符号如规范中所定义。上述酰胺衍生物及其光学活性形式和药学上可接受的盐被认为是治疗或预防由C5a引起的炎症所致疾病或综合症的药物,例如自身免疫性疾病,如风湿病,系统性红斑狼疮等,败血症,成人呼吸窘迫综合症,慢性阻塞性肺疾病,过敏性疾病,如哮喘等,动脉硬化,心脏梗塞,脑梗塞,牛皮癣,阿尔茨海默病和严重器官损伤(例如,肺炎,肾炎,肝炎,胰腺炎等),由缺血再灌注,创伤,烧伤,手术侵袭等引起的白细胞激活所致。此外,它们还可用作通过C5a受体侵入的细菌和病毒引起的传染病的治疗或预防剂。
  • NOVEL AMIDE DERIVATIVES AND MEDICINAL USE THEREOF UGS
    申请人:Mitsubishi Pharma Corporation
    公开号:EP1318140A1
    公开(公告)日:2003-06-11
    The present invention relates to an amide derivative of the formula (1), having a C5a receptor antagonistic action wherein each symbol is as defined in the specification. The above-mentioned amide derivative, an optically active form thereof and a pharmaceutically acceptable salt thereof are promising as an agent for the treatment or prophylaxis of diseases or syndromes caused by inflammation caused by C5a [e.g., autoimmune diseases such as rheumatism, systemic lupus erythematosus and the like, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergic diseases such as asthma and the like, atherosclerosis, cardiac infarction, brain infarction, psoriasis, Alzheimer's disease and serious organ injury (e.g., pneumonia, nephritis, hepatitis and pancreatitis and the like) due to activation of leukocytes caused by ischemia reperfusion, trauma, burn, surgical invasion and the like]. Moreover, they are useful as a therapeutic or prophylactic agent for the infectious diseases caused by bacteria and virus that invade via a C5a receptor.
    本发明涉及一种具有 C5a 受体拮抗作用的式 (1) 酰胺衍生物 其中各符号如说明书中所定义。 上述酰胺衍生物、其光学活性形式及其药学上可接受的盐有望用作治疗或预防由 C5a 引起的炎症所导致的疾病或综合征[例如、自身免疫性疾病,如风湿病、系统性红斑狼疮等;败血症;成人呼吸窘迫综合征;慢性阻塞性肺病;过敏性疾病,如哮喘等;动脉粥样硬化;心肌梗塞;脑梗塞;银屑病;老年痴呆症;严重器官损伤(如:肺炎、肾炎、肝硬化等)、由于缺血再灌注、创伤、烧伤、手术侵袭等引起的白细胞活化而导致的严重器官损伤(如肺炎、肾炎、肝炎和胰腺炎等)]。此外,它们还是治疗或预防细菌和病毒通过 C5a 受体入侵引起的感染性疾病的有效药物。
  • US7855297B2
    申请人:——
    公开号:US7855297B2
    公开(公告)日:2010-12-21
  • US8198454B2
    申请人:——
    公开号:US8198454B2
    公开(公告)日:2012-06-12
查看更多

同类化合物

(S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (R)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (4S,5R)-3,3a,8,8a-四氢茚并[1,2-d]-1,2,3-氧杂噻唑-2,2-二氧化物-3-羧酸叔丁酯 (3aS,8aR)-2-(吡啶-2-基)-8,8a-二氢-3aH-茚并[1,2-d]恶唑 (3aS,3''aS,8aR,8''aR)-2,2''-环戊二烯双[3a,8a-二氢-8H-茚并[1,2-d]恶唑] (1α,1'R,4β)-4-甲氧基-5''-甲基-6'-[5-(1-丙炔基-1)-3-吡啶基]双螺[环己烷-1,2'-[2H]indene 齐洛那平 鼠完 麝香 风铃醇 颜料黄138 雷美替胺杂质14 雷美替胺杂质 雷美替胺杂质 雷美替胺杂质 雷美替胺杂质 雷美替胺杂质 雷美替胺 雷沙吉兰杂质8 雷沙吉兰杂质5 雷沙吉兰杂质4 雷沙吉兰杂质3 雷沙吉兰杂质15 雷沙吉兰杂质12 雷沙吉兰杂质 雷沙吉兰 阿替美唑盐酸盐 铵2-(1,3-二氧代-2,3-二氢-1H-茚-2-基)-8-甲基-6-喹啉磺酸酯 金粉蕨辛 金粉蕨亭 重氮正癸烷 酸性黄3[CI47005] 酒石酸雷沙吉兰 还原茚三酮(二水) 还原茚三酮 过氧化,2,3-二氢-1H-茚-1-基1,1-二甲基乙基 表蕨素L 螺双茚满 螺[茚-2,4-哌啶]-1(3H)-酮盐酸盐 螺[茚-2,4'-哌啶]-1(3H)-酮 螺[茚-1,4-哌啶]-3(2H)-酮盐酸盐 螺[环丙烷-1,2'-茚满]-1'-酮 螺[二氢化茚-1,4'-哌啶] 螺[1H-茚-1,4-哌啶]-3(2H)-酮 螺[1H-茚-1,4-哌啶]-1,3-二羧酸, 2,3-二氢- 1,1-二甲基乙酯 螺[1,2-二氢茚-3,1'-环丙烷] 藏花茚 蕨素 Z 蕨素 D 蕨素 C